Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes.

Current Atherosclerosis Reports
Martial G Bourassa, Colin Berry

Abstract

Diabetes mellitus (DM) is a worldwide epidemic. Its prevalence is rapidly increasing in both developing and developed countries. Coronary heart disease (CHD) is highly prevalent and is the major cause of morbidity and mortality in patients with diabetes. Individuals with prediabetes states, with or without known CHD, should undergo lifestyle modifications aimed at preventing DM. In patients with CHD and DM, routine use of aspirin and an angiotensin-converting enzyme inhibitor, along with strict glycemic, blood pressure, and lipid control, is strongly recommended. Intense insulin therapy may be needed for glycemic control, and high-dose statin therapy may be needed for lipid control. For blood pressure control, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are considered first-line therapy. Noncompliance with medications and/or lifestyle measures and underprescription of evidence-based therapies remain important unsolved problems.

References

Jan 13, 2006·JAMA : the Journal of the American Medical Association·Deepak L BhattUNKNOWN REACH Registry Investigators
Feb 2, 2006·Annals of Family Medicine·Stephen J SpannRobert J Volk
Feb 10, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Claire Kendall, Eric Wooltorton
Feb 16, 2006·JAMA : the Journal of the American Medical Association·F Xavier Pi-SunyerUNKNOWN RIO-North America Study Group
Apr 22, 2006·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Robert E Ratner, UNKNOWN Diabetes Prevention Program Research
Apr 22, 2006·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Jean-Louis Chiasson
Jul 4, 2006·The American Journal of Cardiology·Michelle F MageeUNKNOWN BARI 2D Trial Investigators
Aug 5, 2006·The American Journal of Medicine·Andrew T YanUNKNOWN Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators
Sep 19, 2006·The New England Journal of Medicine·UNKNOWN DREAM Trial InvestigatorsRury R Holman
Nov 15, 2006·JAMA : the Journal of the American Medical Association·Theodore MazzoneSteven M Haffner
Dec 6, 2006·The New England Journal of Medicine·Steven E KahnUNKNOWN ADOPT Study Group
Dec 16, 2006·The Journal of Clinical Hypertension·William C Cushman, Jan Basile
Feb 13, 2007·Journal of the American College of Cardiology·Colin BerryMartial G Bourassa
Feb 16, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Matteo AnselminoUNKNOWN Euro Heart Survey Investigators
Feb 27, 2007·The American Journal of Medicine·Louis J Aronne
Mar 16, 2007·Clinical Pharmacology and Therapeutics·L R JonesT A Wadden
Mar 28, 2007·The New England Journal of Medicine·Steven E NissenUNKNOWN ILLUSTRATE Investigators
May 23, 2007·The New England Journal of Medicine·Steven E Nissen, Kathy Wolski
Jun 7, 2007·The New England Journal of Medicine·Philip D HomeUNKNOWN RECORD Study Group
Jul 12, 2007·The American Journal of Cardiology·UNKNOWN ACCORD Study GroupMark D Sullivan
Jul 12, 2007·The American Journal of Cardiology·Henry N GinsbergUNKNOWN ACCORD Study Group
Aug 21, 2007·JAMA : the Journal of the American Medical Association·Sean M DonahoeElliott M Antman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.